The DOI matches its Crossref record; 85 of the 85 references it cites were found in a registry or an index.
The purines: Potent and versatile small molecule inhibitors and modulators of key biological targets
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A small molecule–kinase interaction map for clinical kinase inhibitors
Fabian, M. A., Biggs, W. H., Treiber, D. K., Atteridge, C. E., Azimioara, M. D., Benedetti, M. G., Carter, T. A., Ciceri, P., Edeen, P. T., Floyd, M., et al. (2005) · Nature Biotechnology · doi:10.1038/nbt1068 · Cited by 1,892
A high-affinity conformation of Hsp90 confers tumour selectivity on Hsp90 inhibitors
Kamal, A., Thao, L., Sensintaffar, J., Zhang, L., Boehm, M. F., Fritz, L. C., & Burrows, F. J. (2003) · Nature · doi:10.1038/nature01913 · Cited by 1,387
The specificities of protein kinase inhibitors: an update
BAIN, J., McLAUCHLAN, H., ELLIOTT, M., & COHEN, P. (2003) · Biochemical Journal · doi:10.1042/bj20021535 · Cited by 1,369
Meijer, L., Borgne, A., Mulner, O., Chong, J. P. J., Blow, J. J., Inagaki, N., Inagaki, M., Delcros, J., & Moulinoux, J. (1997) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1997.t01-2-00527.x · Cited by 1,352
Exploiting Chemical Libraries, Structure, and Genomics in the Search for Kinase Inhibitors
Gray, N. S., Wodicka, L., Thunnissen, A.-M. W. H., Norman, T. C., Kwon, S., Espinoza, F. H., Morgan, D. O., Barnes, G., LeClerc, S., Meijer, L., et al. (1998) · Science · doi:10.1126/science.281.5376.533 · Cited by 808
Vorbrüggen, H., Krolikiewicz, K., & Bennua, B. (1981) · Chemische Berichte · doi:10.1002/cber.19811140404 · Cited by 763
De Azevedo, W. F., Leclerc, S., Meijer, L., Havlicek, L., Strnad, M., & Kim, S. (1997) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1997.0518a.x · Cited by 729
Molecular Biologist's Guide to Proteomics
Graves, P. R., & Haystead, T. A. J. (2002) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.66.1.39-63.2002 · Cited by 691
Inhibition of Cyclin‐Dependent Kinases by Purine Analogues
Veselý, J., Havliček, L., Strnad, M., Blow, J. J., Donella‐Deana, A., Pinna, L., Letham, D. S., Kato, J., Detivaud, L., Leclerc, S., et al. (1994) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1994.00771.x · Cited by 632
Sulfotransferases: Structure, Mechanism, Biological Activity, Inhibition, and Synthetic Utility
Chapman, E., Best, M. D., Hanson, S. R., & Wong, C. (2004) · Angewandte Chemie International Edition · doi:10.1002/anie.200300631 · Cited by 543
Pharmacological inhibitors of cyclin-dependent kinases
Knockaert, M., Greengard, P., & Meijer, L. (2002) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(02)02071-0 · Cited by 537
HSP90 as a new therapeutic target for cancer therapy: the story unfolds
Maloney, A., & Workman, P. (2002) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2.1.3 · Cited by 531
Adenosine receptors: pharmacology, structure-activity relationships, and therapeutic potential
Jacobson, K. A., Van Galen, P. J. M., & Williams, M. (1992) · Journal of Medicinal Chemistry · doi:10.1021/jm00081a001 · Cited by 456
Structural basis of inhibitor selectivity in MAP kinases
Wang, Z., Canagarajah, B. J., Boehm, J. C., Kassisà, S., Cobb, M. H., Young, P. R., Abdel-Meguid, S., Adams, J. L., & Goldsmith, E. J. (1998) · Structure · doi:10.1016/s0969-2126(98)00113-0 · Cited by 423
McClue, S. J., Blake, D., Clarke, R., Cowan, A., Cummings, L., Fischer, P. M., MacKenzie, M., Melville, J., Stewart, K., Wang, S., et al. (2002) · International Journal of Cancer · doi:10.1002/ijc.10738 · Cited by 364
Roscovitine and Other Purines as Kinase Inhibitors. From Starfish Oocytes to Clinical Trials
Meijer, L., & Raymond, E. (2003) · ChemInform · doi:10.1002/chin.200336265 · Cited by 362
Nucleoside transporters: molecular biology and implications for therapeutic development
Baldwin, S. A., Mackey, J. R., Cass, C. E., & Young, J. D. (1999) · Molecular Medicine Today · doi:10.1016/s1357-4310(99)01459-8 · Cited by 349
Protein kinases as targets for anticancer agents: from inhibitors to useful drugs
Fabbro, D., Ruetz, S., Buchdunger, E., Cowan-Jacob, S. W., Fendrich, G., Liebetanz, J., Mestan, J., O'Reilly, T., Traxler, P., Chaudhuri, B., et al. (2002) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(02)00179-1 · Cited by 335
Strategies to overcome resistance to targeted protein kinase inhibitors
Daub, H., Specht, K., & Ullrich, A. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1579 · Cited by 334
Chiosis, G., Timaul, M. N., Lucas, B., Munster, P. N., Zheng, F. F., Sepp-Lorenzino, L., & Rosen, N. (2001) · Chemistry & Biology · doi:10.1016/s1074-5521(01)00015-1 · Cited by 288
MacCallum, D. E., Melville, J., Frame, S., Watt, K., Anderson, S., Gianella-Borradori, A., Lane, D. P., & Green, S. R. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0233 · Cited by 288
Dedifferentiation of Lineage-Committed Cells by a Small Molecule
Chen, S., Zhang, Q., Wu, X., Schultz, P. G., & Ding, S. (2004) · Journal of the American Chemical Society · doi:10.1021/ja037390k · Cited by 286
The Chemodiversity of Purine as a Constituent of Natural Products
Rosemeyer, H. (2004) · Chemistry & Biodiversity · doi:10.1002/cbdv.200490033 · Cited by 283
Adenosine receptors: new opportunities for future drugs
Poulsen, S.-A., & Quinn, R. J. (1998) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(98)00038-8 · Cited by 280
Chang, Y.-T., Gray, N. S., Rosania, G. R., Sutherlin, D. P., Kwon, S., Norman, T. C., Sarohia, R., Leost, M., Meijer, L., & Schultz, P. G. (1999) · Chemistry & Biology · doi:10.1016/s1074-5521(99)80048-9 · Cited by 268
Structure-Activity Relationships in Purine-Based Inhibitor Binding to HSP90 Isoforms
Wright, L., Barril, X., Dymock, B., Sheridan, L., Surgenor, A., Beswick, M., Drysdale, M., Collier, A., Massey, A., Davies, N., et al. (2004) · Chemistry & Biology · doi:10.1016/j.chembiol.2004.03.033 · Cited by 268
Azathioprine: old drug, new actions
Maltzman, J. S., & Koretzky, G. A. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18384 · Cited by 268
Cladribine therapy for systemic mastocytosis
Kluin-Nelemans, H. C. (2003) · Blood · doi:10.1182/blood-2003-05-1699 · Cited by 248
Kanda, T., Jackson, M. J., Smith, L. A., Pearce, R. K. B., Nakamura, J., Kase, H., Kuwana, Y., & Jenner, P. (2000) · Experimental Neurology · doi:10.1006/exnr.2000.7350 · Cited by 248
Therapeutic potential of adenosine A2A receptor antagonists in Parkinson's disease
Xu, K., Bastia, E., & Schwarzschild, M. (2005) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2004.10.007 · Cited by 244
Purmorphamine Induces Osteogenesis by Activation of the Hedgehog Signaling Pathway
Wu, X., Walker, J., Zhang, J., Ding, S., & Schultz, P. G. (2004) · Chemistry & Biology · doi:10.1016/j.chembiol.2004.06.010 · Cited by 224
A non-ATP-competitive inhibitor of BCR-ABL overrides imatinib resistance
Gumireddy, K., Baker, S. J., Cosenza, S. C., John, P., Kang, A. D., Robell, K. A., Reddy, M. V. R., & Reddy, E. P. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408283102 · Cited by 220
Structure-based design of a potent purine-based cyclin-dependent kinase inhibitor
Davies, T. G., Bentley, J., Arris, C. E., Boyle, F. T., Curtin, N. J., Endicott, J. A., Gibson, A. E., Golding, B. T., Griffin, R. J., Hardcastle, I. R., et al. (2002) · Nature Structural Biology · doi:10.1038/nsb842 · Cited by 219
A Small Molecule with Osteogenesis-Inducing Activity in Multipotent Mesenchymal Progenitor Cells
Wu, X., Ding, S., Ding, Q., Gray, N. S., & Schultz, P. G. (2002) · Journal of the American Chemical Society · doi:10.1021/ja0283908 · Cited by 212
O'Hare, T., Pollock, R., Stoffregen, E. P., Keats, J. A., Abdullah, O. M., Moseson, E. M., Rivera, V. M., Tang, H., Metcalf, C. A., Bohacek, R. S., et al. (2004) · Blood · doi:10.1182/blood-2004-05-1851 · Cited by 200
Chiosis, G., Lucas, B., Shtil, A., Huezo, H., & Rosen, N. (2002) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(02)00253-5 · Cited by 195
Mechanism-based design of a protein kinase inhibitor.
Hubbard, S. R., Cole, P. A., Parang, K., Till, J. H., Ablooglu, A. J., & Kohanski, R. A. (2001) · Nature Structural Biology · doi:10.1038/83028 · Cited by 192
Llauger, L., He, H., Kim, J., Aguirre, J., Rosen, N., Peters, U., Davies, P., & Chiosis, G. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm049012b · Cited by 191
Kim, Y.-C., Ji, X.-D., Melman, N., Linden, J., & Jacobson, K. A. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm990421v · Cited by 176
Gilligan, P. J., Robertson, D. W., & Zaczek, R. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm990590f · Cited by 160
Hockemeyer, J., Burbiel, J. C., & Müller, C. E. (2004) · The Journal of Organic Chemistry · doi:10.1021/jo0358574 · Cited by 141
A Three-Hybrid Approach to Scanning the Proteome for Targets of Small Molecule Kinase Inhibitors
Becker, F., Murthi, K. K., Smith, C. C., Come, J. H., COSTAROLDAN, N., Kaufmann, C. M., Hanke, U., Degenhart, C., Baumann, S. W., Wallner, W., et al. (2004) · Chemistry & Biology · doi:10.1016/j.chembiol.2004.02.001 · Cited by 139
Kontopidis, G. A., Wu, S., Zheleva, D. I., Taylor, P., McInnes, C., Lane, D. P., Fischer, P. M., & Walkinshaw, M. D. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0406540102 · Cited by 135
A Structure-Based Library Approach to Kinase Inhibitors
Norman, T., Gray, N. S., Koh, J. T., & Schultz, P. G. (1996) · Journal of the American Chemical Society · doi:10.1021/ja9614934 · Cited by 133
Manallack, D. T., Hughes, R. A., & Thompson, P. E. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm040217u · Cited by 132
Hardcastle, I. R., Arris, C. E., Bentley, J., Boyle, F. T., Chen, Y., Curtin, N. J., Endicott, J., Gibson, A. E., Golding, B. T., Griffin, R. J., et al. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm0311442 · Cited by 130
9-Benzylpurines with inhibitory activity against Mycobacterium tuberculosis
Bakkestuen, A. K., Gundersen, L., Langli, G., Liu, F., & Nolsøe, J. M. J. (2000) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(00)00188-8 · Cited by 124
CDK inhibitors in clinical development for the treatment of cancer
Fischer, P. M., & Gianella-Borradori, A. (2003) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.12.6.955 · Cited by 121
Mitogen‐activated protein kinases and asthma
Pelaia, G., Cuda, G., Vatrella, A., Gallelli, L., Caraglia, M., Marra, M., Abbruzzese, A., Caputi, M., Maselli, R., Costanzo, F. S., et al. (2004) · Journal of Cellular Physiology · doi:10.1002/jcp.20169 · Cited by 120
Harada, H., Asano, O., Hoshino, Y., Yoshikawa, S., Matsukura, M., Kabasawa, Y., Niijima, J., Kotake, Y., Watanabe, N., Kawata, T., et al. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm990499b · Cited by 111
Laufer, S., Domeyer, D. M., Scior, T., Albrecht, W., & Hauser, D. R. J. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm0408767 · Cited by 108
Development of Purine-Scaffold Small Molecule Inhibitors of Hsp90
Chiosis, G., Lucas, B. S., Huezo, H., Solit, D. B., Basso, A., & Rosen, N. X. (2003) · Current Cancer Drug Targets · doi:10.2174/1568009033481778 · Cited by 106
Adenosine A2A antagonists with potent anti-cataleptic activity
Shimada, J., Koike, N., Nonaka, H., Shiozaki, S., Yanagawa, K., Kanda, T., Kobayashi, H., Ichimura, M., Nakamura, J., Kase, H., et al. (1997) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(97)00440-x · Cited by 105
Yu, C., Rahmani, M., Dai, Y., Conrad, D. H., Krystal, G. W., Dent, P., & Grant, S. (2003) · PubMed · Cited by 97
Arnold, L. D., Calderwood, D. J., Dixon, R. W., Johnston, D. N., Kamens, J., Munschauer, R., Rafferty, P., & Ratnofsky, S. E. (2000) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(00)00441-8 · Cited by 93
Legraverend, M., Tunnah, P., Noble, M. E. M., Ducrot, P., Ludwig, O., Grierson, D. S., Leost, M., Meijer, L., & Endicott, J. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm9911130 · Cited by 90
Self-citationNorman, M. H., Chen, N., Chen, Z., Fotsch, C. H., Hale, C., Han, N., Hurt, R., Jenkins, T. J., Kincaid, J., Liu, L., et al. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm000269t · Cited by 85
2,6,9-trisubstituted purines : Optimization towards highly potent and selective CDK1 inhibitors
Imbach, P. A., Capraro, H., Furet, P., Mett, H., Meyer, T., & Zimmermann, J. (1999) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(98)00691-x · Cited by 83
Inhibition and Reversal of Myogenic Differentiation by Purine-Based Microtubule Assembly Inhibitors
Perez, O. D., Chang, Y., Rosania, G. R., Sutherlin, D., & Schultz, P. G. (2002) · Chemistry & Biology · doi:10.1016/s1074-5521(02)00131-x · Cited by 73
Purine-Based Inhibitors of Inositol-1,4,5-trisphosphate-3-kinase
Chang, Y., Choi, G., Bae, Y., Burdett, M. T., Moon, H.-S., Lee, J. W., Gray, N. S., Schultz, P. G., Meijer, L., Chung, S., et al. (2002) · ChemBioChem · doi:10.1002/1439-7633(20020902)3:9<897::aid-cbic897>3.0.co;2-b · Cited by 69
Synthesis and biological activity of olomoucine II
Kryštof, V., Lenobel, R., Havlíček, L., Kuzma, M., & Strnad, M. (2002) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(02)00693-5 · Cited by 68
Identification of a Novel Protein Regulating Microtubule Stability through a Chemical Approach
Wignall, S. M., Gray, N. S., Chang, Y., Juarez, L., Jacob, R. J., Burlingame, A. L., Schultz, P. G., & Heald, R. (2004) · Chemistry & Biology · doi:10.1016/j.chembiol.2003.12.019 · Cited by 68
Dymock, B. W., Barril, X., Beswick, M., Collier, A. J., Davies, N., Drysdale, M., Fink, A., Fromont, C., Hubbard, R. E., Massey, A. J., et al. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2003.11.011 · Cited by 68
Tyrosine kinase inhibitors in cancer treatment (Part II)
Traxler, P. M. (1998) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.8.12.1599 · Cited by 68
Perreira, M., Jiang, J., Klutz, A. M., Gao, Z., Shainberg, A., Lu, C., Thomas, C. J., & Jacobson, K. A. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm050221l · Cited by 66
Vu, C. B., Pan, D., Peng, B., Kumaravel, G., Smits, G. J., Jin, X., Phadke, D., Engber, T. M., Huang, C., Reilly, J., et al. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm0498396 · Cited by 62
Dreyer, M., Borcherding, D. R., Dumont, J. A., Peet, N. P., Tsay, J. T., Wright, P. S., Bitonti, A. J., Shen, J., & Kim, S. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm001043t · Cited by 61
Discovery of Carbohydrate Sulfotransferase Inhibitors from a Kinase-Directed Library
Armstrong, J. I., Portley, A. R., Chang, Y., Nierengarten, D. M., Cook, B. N., Bowman, K. G., Bishop, A., Gray, N. S., Shokat, K. M., Schultz, P. G., et al. (2000) · Angewandte Chemie International Edition · Cited by 61
Corbin, A. S., Demehri, S., Griswold, I. J., Wang, Y., Metcalf, C. A., Sundaramoorthi, R., Shakespeare, W. C., Snodgrass, J. T., Wardwell, S., Dalgarno, D. C., et al. (2005) · Blood · doi:10.1182/blood-2004-12-4771 · Cited by 60
Wu, B., Lin, R., Lo, Y., Shen, K., Wang, C., Lin, Y., & Chen, I. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705791 · Cited by 49
Advances in the treatment of hairy-cell leukaemia
Mey, U., Strehl, J., Gorschlüter, M., Ziske, C. G., Glasmacher, A., Pralle, H., & Schmidt‐Wolf, I. G. H. (2003) · The Lancet Oncology · doi:10.1016/s1470-2045(03)00980-x · Cited by 48
Resin-Capture and Release Strategy toward Combinatorial Libraries of 2,6,9-Substituted Purines
Ding, S., Gray, N. S., Ding, Q., Wu, X., & Schultz, P. G. (2002) · Journal of Combinatorial Chemistry · doi:10.1021/cc010080i · Cited by 47
A Concise and Traceless Linker Strategy toward Combinatorial Libraries of 2,6,9-Substituted Purines
Ding, S., Gray, N. S., Ding, Q., & Schultz, P. G. (2001) · The Journal of Organic Chemistry · doi:10.1021/jo016010f · Cited by 46
Chemical Inhibitors of Cyclin-Dependent Kinases
Noble, M. E. M., & Endicott, J. (1999) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(98)00051-5 · Cited by 45
Raynaud, F. I., Fischer, P. M., Nutley, B. P., et al. (2004) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.353.3.3 · Cited by 44
Traceless solid-phase synthesis of 2,6,9-trisubstituted purines from resin bound 6-thiopurines
Brun, V., Legraverend, M., & Grierson, D. S. (2002) · Tetrahedron · doi:10.1016/s0040-4020(02)00905-5 · Cited by 43
Self-citationA Potent and Highly Selective Sulfotransferase Inhibitor
Chapman, E., Ding, S., Schultz, P. G., & Wong, C. (2002) · Journal of the American Chemical Society · doi:10.1021/ja021086u · Cited by 42
Novel bone-targeted Src tyrosine kinase inhibitor drug discovery.
Shakespeare, W. C., Metcalf, C. A., Wang, Y., Sundaramoorthi, R., Keenan, T. P., Weigele, M., Bohacek, R. S., Dalgarno, D. C., & Sawyer, T. K. (2003) · PubMed · Cited by 41
Haesslein, J., & Jullian, N. (2002) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026023393291 · Cited by 31
Chapman, T. (2004) · Nature · doi:10.1038/430109a · Cited by 29
Pyrazolo[4,3-d]pyrimidines as new generation of cyclin-dependent kinase inhibitors
Moravcová, D., Kryštof, V., Havlíček, L., Moravec, J., Lenobel, R., & Strnad, M. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(03)00631-0 · Cited by 29
2,6,8,9-Tetrasubstituted Purines as New CDK1 Inhibitors
Moravec, J., Kryštof, V., Hanuš, J., Havlíček, L., Moravcová, D., Fuksová, K., Kuzma, M., Lenobel, R., Otyepka, M., & Strnad, M. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(03)00632-2 · Cited by 28
Boyle, C. D., Xu, R., Asberom, T., Chackalamannil, S., Clader, J. W., Greenlee, W. J., Guzik, H. S., Hu, Y., Hu, Z., Lankin, C. M., et al. (2005) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2005.02.083 · Cited by 26
Rumbo, C., Shneider, B. L., & Emre, S. (2004) · Pediatric Transplantation · doi:10.1111/j.1399-3046.2004.00230.x · Cited by 20
Targeted therapies for cancer – from tamoxifen to gefitinib (‘Iressa’)
Hanke, J. H., & Hughes, L. (2004) · Drug Discovery Today Therapeutic Strategies · doi:10.1016/j.ddstr.2004.11.002 · Cited by 3
Cited by
Meijer, L., Nelson, D. J., Riazanski, V., Gabdoulkhakova, A. G., Hery-Arnaud, G., Le Berre, R., Loaëc, N., Oumata, N., Galons, H., Nowak, E., et al. (2016) · Journal of Innate Immunity · doi:10.1159/000444256 · Cited by 4,992
Caffeine analogs: biomedical impact
Daly, J. W. (2007) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-7051-9 · Cited by 256
Roscovitine-Derived, Dual-Specificity Inhibitors of Cyclin-Dependent Kinases and Casein Kinases 1
Oumata, N., Bettayeb, K., Ferandin, Y., Demange, L., Lopez-Giral, A., Goddard, M.-L., Myrianthopoulos, V., Mikros, E., Flajolet, M., Greengard, P., et al. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm800109e · Cited by 139
Estrogen receptor ligands: a review (2013-2015)
Farzaneh, S., & Zarghi, A. (2016) · Scientia Pharmaceutica · doi:10.3390/scipharm84030409 · Cited by 71
Metadata
- Authors
- Legraverend, M., & Grierson, D. S.
- Venue
- Bioorganic & Medicinal Chemistry
- Publisher
- Elsevier BV
- Published
- 2006-06
- Volume
- 14
- Issue
- 12
- Pages
- 3987-4006
- ISSN
- 0968-0896 (ISSN-L)
- OpenAlex
- W1978953318
- Cited by
- 330
- References
- 85
- FWCI
- 9.40
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.